Stericycle (SRCL)
(Delayed Data from NSDQ)
$60.88 USD
-0.01 (-0.02%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $60.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$60.88 USD
-0.01 (-0.02%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $60.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Zacks News
Mastercard (MA) Teams Up to Make Digital Payments Safer in Egypt
by Zacks Equity Research
Mastercard (MA) joins forces with ALEXBANK to launch innovative payment solutions for the bank's cardholder base and make its cybersecurity solutions available for accelerating digital transformation efforts in Egypt.
SRCL vs. WM: Which Stock Is the Better Value Option?
by Zacks Equity Research
SRCL vs. WM: Which Stock Is the Better Value Option?
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Stericycle (SRCL) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Stericycle's (SRCL) Stock Gains 6% Post Q4 Earnings Beat
by Zacks Equity Research
Stericycle (SRCL) witnesses weak segmental performance in fourth-quarter 2023.
Stericycle (SRCL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Stericycle (SRCL) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Stericycle (SRCL) Beats Q4 Earnings Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 14.89% and 0.83%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Insights Into Stericycle (SRCL) Q4: Wall Street Projections for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Stericycle (SRCL) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
GFL Environmental Inc. (GFL) Misses Q4 Earnings Estimates
by Zacks Equity Research
GFL Environmental Inc. (GFL) delivered earnings and revenue surprises of -77.78% and 1.29%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Waste Connections (WCN) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Waste Connections (WCN) delivered earnings and revenue surprises of 2.78% and 0.03%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
SRCL vs. WCN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SRCL vs. WCN: Which Stock Is the Better Value Option?
Zacks Industry Outlook Highlights Waste Management, Republic Services and Stericycle
by Zacks Equity Research
Waste Management, Republic Services and Stericycle have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Highlights Waste Management, Republic Services and Stericycle
by Zacks Equity Research
Waste Management, Republic Services and Stericycle are part of the Zacks Industry Outlook article.
Time to Buy These 3 Stocks from a Prospering Waste Removal Sector
by Soumyadeep Bose
Waste Management thrives on tech integration, regulations and environmental awareness amid industrialization and urbanization. WM, RSG and SRCL are likely to be gainers from the ongoing trends.
SRCL or WCN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
SRCL vs. WCN: Which Stock Is the Better Value Option?
Stericycle (SRCL) Rises 10% in the Past 3 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) has strong customer relationships, most of which include long-term contracts.
Reasons Why You Should Hold on to Stericycle (SRCL) Now
by Zacks Equity Research
Stericycle (SRCL) is gaining from its transformation initiative launched in 2017 and its robust acquisition strategy.
Stericycle (SRCL) Stock Rises 13% in a Month: Here's How
by Zacks Equity Research
Stericycle (SRCL) is progressing well with its key objectives, including improving the quality of revenues and driving operational efficiency.
Stericycle (SRCL) Barely Moves Despite In-Line Q3 Earnings
by Zacks Equity Research
Stericycle (SRCL) reports a year-over-year decrease in revenues and earnings in the third quarter of 2023.
Stericycle (SRCL) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Stericycle (SRCL) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Stericycle (SRCL) Matches Q3 Earnings Estimates
by Zacks Equity Research
Stericycle (SRCL) delivered earnings and revenue surprises of 0% and 3.94%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Stericycle (SRCL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Stericycle (SRCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SRCL vs. WCN: Which Stock Is the Better Value Option?
by Zacks Equity Research
SRCL vs. WCN: Which Stock Is the Better Value Option?
Why Should Stericycle (SRCL) Stock Grace Your Portfolio Now?
by Zacks Equity Research
Stericycle (SRCL) gains from a strong acquisition strategy and long-term customer contracts.
Stericycle (SRCL) Stock Rises 10% in 6 Months: Here's How
by Zacks Equity Research
Stericycle (SRCL) is progressing well with its key objectives, including improving the quality of revenues and driving operational efficiency.